Rabindra Tirouvanziam, PhD

Associate Professor
Emory University

Poster(s):

• (384) Impact of elexacaftor/tezacaftor/ivacaftor therapy on the pathological reprogramming of lung-recruited neutrophils conditioned by cystic fibrosis airway fluid
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (386) Myeloperoxidase activity and methionine oxidation products in bronchoalveolar lavage are associated with heightened risk of bronchiectasis in CF infants and toddlers
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (414) Longitudinal analysis of early life bronchoalveolar fluid identifies immune mediators associated with bronchiectasis risk in children with CF
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (446) Metabolites in Early Life Bronchoalveolar Fluid Associate With Future Bronchiectasis Risk in Children With Cystic Fibrosis
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET